Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-21

FDA Approved: FOSAPREPITANT — Supplemental Application (Dr. Reddy's Laboratories Inc.,)

View source ↗

Summary

FDA approved a supplemental application for fosaprepitant submitted by Dr. Reddy's Laboratories Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

SUPPL AP for FOSAPREPITANT (FOSAPREPITANT)